Saatja: "ECDC Microbiology" <
[email protected]>
Saaja: "Indra Alexander" <
[email protected]>, "Apfalter Petra" <
[email protected]>, "Wesley.Mattheus" <
[email protected]>, "steven.vangucht" <
[email protected]>, "ivanoov" <
[email protected]>, "stefka.krumova" <
[email protected]>, "ljiljana.zmak" <
[email protected]>, "selma.bosnjak" <
[email protected]>, "Ivana Ferenčak" <
[email protected]>, "m.mendris" <
[email protected]>, "Fani Theophanous" <
[email protected]>, "dpieridou" <
[email protected]>, "ckaragiannis" <
[email protected]>, "Zuzana Okonji" <
[email protected]>, "pavla.krizova" <
[email protected]>, "Kristina Træholt Franck" <
[email protected]>, "Eva Møller Nielsen" <
[email protected]>, "Liisi Kink" <
[email protected]>, "Salmenlinna Saara" <
[email protected]>, "Savolainen-Kopra Carita" <
[email protected]>, "Mathieu TOURDJMAN" <
[email protected]>, "CASTRO-ALVAREZ Javier" <
[email protected]>, "mankertza" <
[email protected]>, "WernerG" <
[email protected]>, "Ιωάννα Σπηλιοπούλου" <
[email protected]>,
[email protected], "Judit Henczkó" <
[email protected]>, "Kristjan Orri Helgason" <
[email protected]>, "Hannes Bjarki Vigfússon" <
[email protected]>, "Kirsten Schaffer" <
[email protected]>, "ARHAI HPSC" <
[email protected]>, "annateresa.palamara" <
[email protected]>, "Stefanelli Paola" <
[email protected]>, "gatis.pakarna" <
[email protected]>, "Walser-Domjan Esther" <
[email protected]>, "Visscher Carla" <
[email protected]>, "svajune.muralyte" <
[email protected]>, "Jonas Žvirgždas" <
[email protected]>, "Trung Nguyen" <
[email protected]>, "claire.marantidis-cordina" <
[email protected]>, "christopher.barbara" <
[email protected]>, "Wanda Han" <
[email protected]>, "Chantal Reusken" <
[email protected]>, "Trine Marie LAbée-Lund Normann" <
[email protected]>, "Christine Genevieve Monceyron Jonassen" <
[email protected]>, "Karoline Bragstad" <
[email protected]>, "Gierczyński Rafał" <
[email protected]>, "a.skoczynska" <
[email protected]>, "Helena Cortes Martins" <
[email protected]>, "Jorge Machado" <
[email protected]>, "Raluca Gatej" <
[email protected]>, "teodora.vremera" <
[email protected]>, "edita.staronova" <
[email protected]>, "lucia.madarova" <
[email protected]>, "Tjaša Žohar Čretnik" <
[email protected]>, "Andrej Steyer" <
[email protected]>, "katarina.prosenc" <
[email protected]>, "ijado" <
[email protected]>, "Horacio Gil Gil" <
[email protected]>, "sara.byfors" <
[email protected]>, "Andreas.Brave" <
[email protected]>
Teema: Public consultation IVDR
Kuupäev: 2025-03-14 14:16
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu
saatja korral palume linke ja faile mitte avada.
To: National Focal Points for Microbiology (members/alternates)
cc. National Coordinators (members/alternates)
Dear National Focal Points for Microbiology,
Regulation (EU) 2017/745 on medical devices (MDR) and Regulation (EU)
2017/746 on in vitro diagnostic medical devices (IVDR) were adopted in 2017.
The Regulations aim to ensure that only safe and effective devices are on
the EU market, to protect patient safety and public health while supporting
innovation.
Considering the extent of the changes introduced by the Regulations,
transition periods were envisaged to ensure a smooth transition to the new
rules. These transition periods continue to apply and due to some
challenges, have been extended. In view of the significant challenges
encountered in transitioning to the new rules the Commission has decided to
launch a targeted evaluation of the Regulations in 2024.
As part of this evaluation the European Commission has opened a public
consultation to receive feedback on the regulation and its impact.
EU rules on medical devices and in vitro diagnostics – targeted evaluation
<https://ec.europa.eu/info/law/better-regulation/have-your-say/initiatives/14155-EU-rules-on-medical-devices-and-in-vitro-diagnostics-targeted-evaluation_en>
We kindly encourage you to provide feedback on this evaluation or share the
link with colleagues who have an interest in this topic and are willing to
contribute. Please be advised that the deadline for submitting feedback is
21 March 2025.
Kind regards,
Daniel Palm
on behalf of the ECDC Microbiology Team
European Centre for Disease Prevention and Control (ECDC)Gustav III:s boulevard 40, 169 73 Solna, Sweden
Phone +46 (0)8 58 60 10 00
<https://www.ecdc.europa.eu/> www.ecdc.europa.eu
Follow ECDC on:
<http://www.facebook.com/ECDC.EU>
<https://bsky.app/profile/ecdc.europa.eu>
<http://www.linkedin.com/company/ecdc>
<http://www.youtube.com/user/ECDCchannel>
<https://www.instagram.com/ecdc.eu>
<https://www.threads.net/@ecdc.eu>
Confidentiality Notice
If you are not the intended recipient of this message, you are hereby kindly
requested, to, consecutively, refrain from disclosing its content to any
third party, delete it and inform its sender of the erroneous transmittal.
Classified as ECDC NORMAL